新綸科技(002341.SZ):侯毅辭去董事、董事長、總裁等職務
格隆匯 1 月 15日丨新綸科技(002341.SZ)公佈,公司董事會於近日收到侯毅的書面辭職報吿,侯毅因個人原因,申請辭去公司第五屆董事會董事、董事長、戰略委員會主任委員及總裁職務。辭去上述職務後侯毅將繼續擔任新綸材料研究院院長職務,統籌公司的新材料前沿技術創新研究,繼續為公司的發展做出貢獻;其辭職自辭職報吿送達董事會時生效。
公司將按照相關程序盡快選舉產生第五屆董事會新任董事長並聘任新的總裁,在產生新任董事長和總裁前,將由副董事長廖垚代理董事長、總裁職務並行使公司法定代表人相關權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.